Hematology / Oncology


Osiem

Osimertinib,40mg – Osimertinib,80mg

osime

Osiem (Osimertinib ,previously known as AZD9291) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug used for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutationpositive non-small cell lung cancer (NSCLC) .

Emlutini

Ibrutinib,140mg

emlutini

Emlutini (Ibrutinib) is a small molecule drug that binds permanently to a protein, Bruton’s tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, Waldenström’s macroglobulinemia, and Marginal zone lymphoma,a form of non-Hodgkin’s lymphoma.

Parcini

Palbociclib, 75mg – Palbociclib, 100mg – Palbociclib, 125mg

parcini

Palbociclib (Palbociclib) is a drug for the treatment of ER-positive and HER2-negative advanced or metastatic breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.

Soranni

Sorafebnib, 200mg

soranni

Soranni (Sorafenib) is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.

Abyrone

Abiraterone, 250mg

abyrone

Abyrone(abiraterone) is a synthetic, steroidal CYP17A1 inhibitor and the active metabolite of abiraterone acetate, an ester and prodrug of abiraterone that is used in the treatment of prostate cancer.

Lemide

Lenalidomide 2.5mg, 5mg, 10mg, 25mg

Lemide

Lemide (lenalidomide)
lenalidomide is a prescription medicine approved in combination with dexamethasone to treat patients with multiple myeloma (a type of cancer of the bone marrow) who already have had prior therapy. It is also approved to treat certain patients who have certain types of myelodysplastic syndromes (a group of conditions in which the bone marrow does not produce enough mature blood cells).